Yearly Archives: 2011

Mu Sigma Closes $108M Funding

Mu Sigma, a Chicago, IL-based provider of analytics and decision support services for global enterprise customers, has closed a $108m funding. The round was led...

Medrobotics Closes $11.7M Series C Funding

Medrobotics Corporation, a Boston, MA-based robotic snake technology developer, recently closed a $11.7m Series C funding. Backers include new angel investors and The Pittsburgh Life...

Zeis Excelsa Receives €20 Investment from Fondo Italiano di Investimento

Zeis Excelsa SpA, a Montegranaro, Italy-based shoe and apparel manufacturer and supplier, has received a €20 investment from Fondo Italiano di Investimento. Fondo Italiano will...

Ventelo Acquired by EQT

Ventelo, a Fornebu (Oslo), Norway-based data and telecom provider, has been acquired by EQT VI for an equity value of up to NOK 1,800m. Sellers...

Tres Amigas Recevies $12M Equity Investment from Mitsui & Co.

Tres Amigas LLC, a Santa Fe, NM, U.S.-based national grid interconnection project known as the Tres Amigas SuperStation, has recevied a $12m equity investment from...

Grupo IMO Receives €20M Equity Investment from Nazca Capital

Grupo IMO, a Spanish provider of radiotherapy services for the treatment of cancer, has received an approximate €20m investment from Nazca Capital. Nazca, which made...

MedAdherence Receives $150K in Pre-Seed Financing from Connecticut Innovations

MedAdherence LLC, a Norwalk, Conn.-based healthcare information technology company, received a $150k Pre-Seed financing from Connecticut Innovations (CI). The company, which has secured required matching...

RemoteReality Closes Series C Funding Round

RemoteReality Corporation, a Putnam, Conn.-based developer of ultra-wide-angle camera systems for military, homeland security and commercial customers, recently closed a Series C round of...

HzO Receives $3M Equity Investment from Horizons Ventures

HzO, a Utah-based provider of technology that protects valuable electronics from water, humidity, and other liquids, has received a $3m equity investment from Hong...

Provenance Biopharmaceuticals Closes $8M Financing with Alopexx Enterprises

Provenance Biopharmaceuticals Corp., a Waltham, MA-based clinical-stage biotechnology company focused on developing novel therapeutics for cancer and other serious, life-threatening diseases, has closed an...

THE DAILY NEWSLETTER - SIGNUP

Latest news